Victoria Song

Interstitial fluid is like this fluid that sits between your cells.

And you can kind of read glucose levels from that.

Yeah.

So previously, if you knew what a CGM was, you likely were a type 1 diabetic or a person who had a type 1 diabetic in your family.

It is diabetes tech, so to speak, because you generally wouldn't have a reason to monitor your glucose levels in real time, which is what this technology does, unless you needed to monitor your insulin levels.

Right now, it's kind of hitting the mainstream much more broadly because in 2024, the FDA cleared them for over-the-counter use.

They have to be different from the CGMs that diabetics use because...

you know, type 1 diabetics, they can't produce insulin or they produce such little levels of insulin as to be not relevant.

And so they need that to help monitor their insulin levels, whereas the ones for non-diabetics, for people who have prediabetes, who have

People who have type 2 diabetes who are not reliant on insulin, these CGMs function a bit differently.

So, yeah.

And, you know, once you open it to the wider public, you get people who are hopping onto this trend of metabolism optimizing.

And that has taken the health world, the wellness world, and the health tech world by storm over the last couple of years and forever.

You know, I've kind of been saying it because I've seen it creeping up, but it is like the number one frontier, I think, for wearable technology.

OK, so about sometime in the summer, I think June 2025, RFK Jr.

basically made this huge statement about how wearable technology is going to be a fundamental pillar of the Maha movement.

And I remember this.

It was about taking control of their health.

And in particular, within the space of wearable technology, he pointed out CGMs as something that could help reverse diabetes.

And, you know, in the diabetic community, the concept of reversing diabetes is a hotly debated one.